PSMD14 and cancer: We found that PSMD14 expression was an independent predictor of worse DFS, and tumors with high expression of PSMD14 were associated with a 2.89-fold increase in the risk of cancer recurrence or metastasis (HR = 2.89, 95% CI [1.247–6.711], P = 0.013) (Table 3).